Rapid Dose Therapeutics Stock Market Value
| RDTCF Stock | USD 0.09 0.00 0.00% |
| Symbol | Rapid |
Rapid Dose 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rapid Dose's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rapid Dose.
| 12/01/2025 |
| 12/31/2025 |
If you would invest 0.00 in Rapid Dose on December 1, 2025 and sell it all today you would earn a total of 0.00 from holding Rapid Dose Therapeutics or generate 0.0% return on investment in Rapid Dose over 30 days. Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes... More
Rapid Dose Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rapid Dose's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rapid Dose Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 63.03 | |||
| Value At Risk | (9.09) |
Rapid Dose Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rapid Dose's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rapid Dose's standard deviation. In reality, there are many statistical measures that can use Rapid Dose historical prices to predict the future Rapid Dose's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.45) | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | 1.37 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rapid Dose's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Rapid Dose Therapeutics Backtested Returns
Rapid Dose Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0249, which implies the firm had a -0.0249 % return per unit of risk over the last 3 months. Rapid Dose Therapeutics exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Rapid Dose's Coefficient Of Variation of (1,370), risk adjusted performance of (0.04), and Variance of 40.94 to confirm the risk estimate we provide. The company holds a Beta of -0.35, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Rapid Dose are expected to decrease at a much lower rate. During the bear market, Rapid Dose is likely to outperform the market. At this point, Rapid Dose Therapeutics has a negative expected return of -0.15%. Please make sure to check Rapid Dose's jensen alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Rapid Dose Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.27 |
Poor predictability
Rapid Dose Therapeutics has poor predictability. Overlapping area represents the amount of predictability between Rapid Dose time series from 1st of December 2025 to 16th of December 2025 and 16th of December 2025 to 31st of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rapid Dose Therapeutics price movement. The serial correlation of 0.27 indicates that nearly 27.0% of current Rapid Dose price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.27 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Rapid Dose Therapeutics lagged returns against current returns
Autocorrelation, which is Rapid Dose pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Rapid Dose's pink sheet expected returns. We can calculate the autocorrelation of Rapid Dose returns to help us make a trade decision. For example, suppose you find that Rapid Dose has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Rapid Dose regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Rapid Dose pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Rapid Dose pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Rapid Dose pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Rapid Dose Lagged Returns
When evaluating Rapid Dose's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Rapid Dose pink sheet have on its future price. Rapid Dose autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Rapid Dose autocorrelation shows the relationship between Rapid Dose pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Rapid Dose Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Rapid Pink Sheet
Rapid Dose financial ratios help investors to determine whether Rapid Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rapid with respect to the benefits of owning Rapid Dose security.